Evidence map›Paper›PMID 30254215›Full record

ArticleEuropean journal of human genetics : EJHG2019

Novel calcineurin A (PPP3CA) variant associated with epilepsy, constitutive enzyme activation and downregulation of protein expression.

Małgorzata Rydzanicz, Małgorzata Wachowska, Erik C Cook, Paweł Lisowski, Bożena Kuźniewska, Krystyna Szymańska, Sebastian Diecke, Alessandro Prigione, Krzysztof Szczałuba, Aleksandra Szybińska and 16 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. [Neuroprotective effects of idebenone combined with borneol via the dopamine signaling pathway in a transgenic zebrafish model of Parkinson's disease].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Investigation of Copy Number Variations (CNVs) of the GoatAnimals : an open access journal from MDPI · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 3 countries.

Małgorzata RydzaniczDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Małgorzata WachowskaDepartment of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Warsaw, Poland.
Erik C CookCenter for Structural Biology and Department of Molecular & Cellular Biochemistry, University of Kentucky, Lexington, USA.
Paweł LisowskiInstitute of Genetics and Animal Breeding of the Polish Academy of Sciences, Jastrzębiec, Poland.
Bożena KuźniewskaCentre of New Technologies, University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0002-9062-847X
Krystyna SzymańskaDepartment of Experimental and Clinical Neuropathology, Mossakowski Medical Research Center, Polish Academy of Sciences, Warsaw, Poland.
Sebastian DieckeMax-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
Alessandro PrigioneMax-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.ORCID http://orcid.org/0000-0001-9457-1952
Krzysztof SzczałubaDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0001-8803-646X
Aleksandra SzybińskaInternational Institute of Molecular and Cell Biology in Warsaw, Warsaw, Poland.
Agnieszka KoppoluDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Victor Murcia PienkowskiDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Joanna KosińskaDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Małgorzata WiwegerInternational Institute of Molecular and Cell Biology in Warsaw, Warsaw, Poland.
Grażyna KostrzewaDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Małgorzata BrzozowskaDepartment of Forensic Medicine, Medical University of Warsaw, Warsaw, Poland.
Dorota Domańska-PakiełaDepartment of Child Neurology and Epileptology, The Children's Memorial Health Institute, Warsaw, Poland.
Elżbieta JurkiewiczDepartment of Diagnostic Imaging, The Children's Memorial Health Institute, Warsaw, Poland.
Piotr StawińskiDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Agnieszka GromadkaDepartment of Bioinformatics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Piotr ZielenkiewiczDepartment of Bioinformatics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.ORCID http://orcid.org/0000-0001-8151-6874
Urszula DemkowDepartment of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Warsaw, Poland.
Magdalena DziembowskaCentre of New Technologies, University of Warsaw, Warsaw, Poland.
Jacek KuźnickiInternational Institute of Molecular and Cell Biology in Warsaw, Warsaw, Poland.
Trevor P CreamerCenter for Structural Biology and Department of Molecular & Cellular Biochemistry, University of Kentucky, Lexington, USA.ORCID http://orcid.org/0000-0001-8868-8724
Rafał PłoskiDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland. rploski@wp.pl.
Medical University of Warsaw · PLInternational Institute of Molecular and Cell Biology · PLMax Delbrück Center · DEChildren's Memorial Health Institute · PLInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PLUniversity of Kentucky · USUniversity of Warsaw · PLMossakowski Medical Research Institute, Polish Academy of Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PPP3CA encodes calmodulin-binding catalytic subunit of calcineurin, a ubiquitously expressed calcium/calmodulin-regulated protein phosphatase. Recently de novo PPP3CA variants were reported as a cause of disease in 12 subjects presenting with epileptic encephalopathy and dysmorphic features. We describe a boy with similar phenotype and severe early onset epileptic encephalopathy in whom a novel de novo c.1324C>T (p.(Gln442Ter)) PPP3CA variant was found by whole exome sequencing. Western blot experiments in patient's cells (EBV transformed lymphocytes and neuronal cells derived through reprogramming) indicate that despite normal mRNA abundance the protein expression level is strongly reduced both for the mutated and wild-type protein. By in vitro studies with recombinant protein expressed in E. coli we show that c.1324C>T (p.(Gln442Ter)) results in constitutive activation of the enzyme. Our results confirm the role of PPP3CA defects in pathogenesis of a distinct neurodevelopmental disorder including severe epilepsy and dysmorphism and provide further functional clues regarding the pathogenic mechanism.

Indexed as

Mutation, MissenseCalcineurinCells, CulturedChildCraniofacial AbnormalitiesDown-RegulationEpilepsyHumansMalePhenotypeSyndromeCalcineurinPPP3CA protein, human

Identifiers

PMID30254215
PMCPMC6303256
OpenAlexW2893934664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.